Validea Motley Fool Strategy Daily Upgrade Report - 8/8/2025
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 08 2025
0mins
Should l Buy VITL?
Source: NASDAQ.COM
Stock Ratings Overview: Validea's Small-Cap Growth Investor model, based on Motley Fool's strategy, has upgraded ratings for several stocks including Hawthorn Bancshares (HWBK) from 65% to 72%, Inter & Co Inc (INTR) from 59% to 85%, and Vital Farms (VITL) from 52% to 79%, indicating improved fundamentals and valuations.
Company Descriptions: Hawthorn Bancshares is a bank holding company offering various banking services; Inter & Co Inc operates as a digital multi-service bank in Brazil; and Vital Farms focuses on ethically produced foods, particularly pasture-raised eggs, emphasizing humane treatment of farm animals.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy VITL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on VITL
Wall Street analysts forecast VITL stock price to rise
12 Analyst Rating
11 Buy
0 Hold
1 Sell
Strong Buy
Current: 8.740
Low
44.00
Averages
48.90
High
60.00
Current: 8.740
Low
44.00
Averages
48.90
High
60.00
About VITL
Vital Farms, Inc. offers a range of ethically produced foods nationwide. The Company is a national consumer brand that works with more than 575 family farms and is the United States brand of pasture-raised eggs. The Company focuses on the humane treatment of farm animals and sustainable farming practices. The Company packages, markets and distributes shell eggs, butter, and other products. Its products, including shell eggs, butter, hard-boiled eggs, and liquid whole eggs, are sold in approximately 23,500 stores nationwide. The retail varieties of its shell eggs are based on supplemental feed type, egg size, and pack size. Its egg packaging consists primarily of corrugated boxes and egg cartons. The Company offers unsalted and sea-salted varieties of its butter, which are sold in two-stick and four-stick packs. The Company’s products are principally sold under the name Vital Farms in addition to other trade names, primarily to retail and foodservice channels in the United States.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Vital Farms Faces Investor Misleading Allegations
- Investigation Launched: Robbins LLP is investigating allegations that Vital Farms, Inc. (VITL) misled investors regarding its business prospects between May 8, 2025, and February 26, 2026, which could lead to significant investor losses.
- ERP Implementation Delays: The lawsuit reveals that Vital Farms acknowledged delays in implementing its enterprise resource planning (ERP) system, despite management's emphasis on its critical role in operational improvements, potentially disrupting shipments and production and affecting retail shelf space.
- Financial Performance Misses: In its 10-K report released on February 26, 2026, Vital Farms reported fiscal year 2025 revenue of $759.44 million, missing the $775 million guidance, and an earnings per share (EPS) of $0.35, below the $0.39 consensus, indicating financial strain on the company.
- Stock Price Decline: Following the release of disappointing financial results, Vital Farms' stock fell by $2.68, or 10.8%, closing at $22.11, reflecting market concerns about the company's future prospects and a decline in investor confidence.
See More
Vital Farms Faces Investor Misleading Allegations
- Lawsuit Allegations: Robbins LLP is investigating whether Vital Farms, Inc. (VITL) misled investors between May 8, 2025, and February 26, 2026, by emphasizing the critical nature of its enterprise resource planning (ERP) system implementation while delaying it, which led to shipment and production delays affecting retail shelf space.
- Financial Performance Miss: The 10-K report released by Vital Farms on February 26, 2026, revealed a revenue of $759.44 million for fiscal year 2025, falling short of the $775 million guidance, with earnings per share (EPS) reported at $0.35, below the market consensus of $0.39, indicating significant operational challenges.
- Stock Price Reaction: Following the release of the disappointing financial report, Vital Farms' stock price dropped by $2.68, or 10.8%, closing at $22.11, reflecting market concerns about the company's future prospects and potentially diminishing investor confidence.
- Class Action Opportunity: Affected shareholders have the opportunity to submit their applications by May 26, 2026, to serve as lead plaintiffs in the class action, representing other shareholders and highlighting investor concerns regarding corporate governance and management accountability.
See More
Vital Farms Faces Class Action Lawsuit Reminder
- Class Action Reminder: The Schall Law Firm reminds investors of a class action lawsuit against Vital Farms for violations of securities laws, involving securities purchased between May 8, 2025, and February 26, 2026, with a deadline to contact the firm by May 26, 2026, for participation.
- False Statements Allegation: The complaint alleges that Vital Farms misled investors by claiming that risks related to its new ERP system were merely hypothetical, resulting in significant investor losses when the truth emerged, indicating that the company's public statements were materially misleading throughout the class period.
- Earnings Miss: Due to delays caused by the ERP system, Vital Farms missed its consensus earnings per share expectations, which not only affected the company's financial performance but also potentially eroded investor confidence, leading to negative impacts on the stock price.
- Legal Consultation Opportunity: The Schall Law Firm offers free consultations and encourages affected investors to reach out to discuss their rights, highlighting the firm's specialization in securities class action lawsuits aimed at helping investors recover their losses.
See More
Vital Farms Securities Class Action Notice
- Class Action Notice: Rosen Law Firm reminds investors who purchased Vital Farms securities between May 8, 2025, and February 26, 2026, that they must apply to be lead plaintiff by May 26, 2026, or risk losing their right to compensation.
- Lawsuit Background: The lawsuit alleges that Vital Farms downplayed the risks associated with delays in its new ERP system rollout, failing to disclose the impact of these delays on its 2025 earnings guidance and EPS consensus, resulting in investor losses when the truth emerged.
- Law Firm's Credentials: Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, being ranked first by ISS Securities Class Action Services in 2017, showcasing its successful track record and expertise in the field.
- Investor Advisory: Investors are advised to choose their legal counsel wisely, as many firms issuing notices lack actual litigation experience; Rosen Law Firm emphasizes selecting counsel with a proven track record to ensure effective protection of their rights.
See More
Vital Farms Securities Class Action Reminder
- Class Action Notice: Rosen Law Firm reminds investors who purchased Vital Farms securities between May 8, 2025, and February 26, 2026, that they must apply to be lead plaintiff by May 26, 2026, or risk losing their representation in the class action lawsuit.
- Potential Compensation Opportunity: Investors participating in the class action may be entitled to compensation without any upfront costs, indicating a risk-free avenue for affected investors to seek recovery, thereby enhancing investor confidence in the process.
- Lawsuit Background: The lawsuit alleges that Vital Farms downplayed the risks associated with delays in rolling out its new ERP system and failed to disclose the impact of these delays on its 2025 earnings guidance and EPS consensus, resulting in investor losses when the truth emerged.
- Law Firm's Advantage: Rosen Law Firm is renowned for its successful track record in securities class actions, having recovered over $438 million for investors in 2019 alone, showcasing its expertise and resource advantages in handling such cases.
See More
Vital Farms Q1 2026 Earnings Call Insights
- Underperformance in Q1: Vital Farms reported net revenue of $187.2 million for Q1 2026, a 15.4% year-over-year increase, yet the results fell short of expectations due to unsustainable price gaps, prompting management to emphasize the need for rapid adaptation to control costs.
- Adjusted EBITDA Guidance: The company has lowered its adjusted EBITDA guidance for 2026 to a range of $0 to $10 million, anticipating a negative impact of $32 million from supply management costs, indicating increased cash flow pressures.
- Strategic Contraction: Vital Farms has decided to exit its butter business and pause construction on the Vital Crossroads facility in Indiana, reducing capital expenditure guidance to $70 million to $75 million, reflecting a cautious approach to future investments.
- Market Outlook: Management expects revenue-generating volume growth to turn positive in Q3 and anticipates growth acceleration in Q4, despite current pricing pressures and oversupply challenges, aiming to restore gross margins to 30% by 2027.
See More
Vital Farms Faces Investor Misleading Allegations
- Investigation Launched: Robbins LLP is investigating allegations that Vital Farms, Inc. (VITL) misled investors regarding its business prospects between May 8, 2025, and February 26, 2026, which could lead to significant investor losses.
- ERP Implementation Delays: The lawsuit reveals that Vital Farms acknowledged delays in implementing its enterprise resource planning (ERP) system, despite management's emphasis on its critical role in operational improvements, potentially disrupting shipments and production and affecting retail shelf space.
- Financial Performance Misses: In its 10-K report released on February 26, 2026, Vital Farms reported fiscal year 2025 revenue of $759.44 million, missing the $775 million guidance, and an earnings per share (EPS) of $0.35, below the $0.39 consensus, indicating financial strain on the company.
- Stock Price Decline: Following the release of disappointing financial results, Vital Farms' stock fell by $2.68, or 10.8%, closing at $22.11, reflecting market concerns about the company's future prospects and a decline in investor confidence.
See More
Vital Farms Faces Investor Misleading Allegations
- Lawsuit Allegations: Robbins LLP is investigating whether Vital Farms, Inc. (VITL) misled investors between May 8, 2025, and February 26, 2026, by emphasizing the critical nature of its enterprise resource planning (ERP) system implementation while delaying it, which led to shipment and production delays affecting retail shelf space.
- Financial Performance Miss: The 10-K report released by Vital Farms on February 26, 2026, revealed a revenue of $759.44 million for fiscal year 2025, falling short of the $775 million guidance, with earnings per share (EPS) reported at $0.35, below the market consensus of $0.39, indicating significant operational challenges.
- Stock Price Reaction: Following the release of the disappointing financial report, Vital Farms' stock price dropped by $2.68, or 10.8%, closing at $22.11, reflecting market concerns about the company's future prospects and potentially diminishing investor confidence.
- Class Action Opportunity: Affected shareholders have the opportunity to submit their applications by May 26, 2026, to serve as lead plaintiffs in the class action, representing other shareholders and highlighting investor concerns regarding corporate governance and management accountability.
See More
Vital Farms Faces Class Action Lawsuit Reminder
- Class Action Reminder: The Schall Law Firm reminds investors of a class action lawsuit against Vital Farms for violations of securities laws, involving securities purchased between May 8, 2025, and February 26, 2026, with a deadline to contact the firm by May 26, 2026, for participation.
- False Statements Allegation: The complaint alleges that Vital Farms misled investors by claiming that risks related to its new ERP system were merely hypothetical, resulting in significant investor losses when the truth emerged, indicating that the company's public statements were materially misleading throughout the class period.
- Earnings Miss: Due to delays caused by the ERP system, Vital Farms missed its consensus earnings per share expectations, which not only affected the company's financial performance but also potentially eroded investor confidence, leading to negative impacts on the stock price.
- Legal Consultation Opportunity: The Schall Law Firm offers free consultations and encourages affected investors to reach out to discuss their rights, highlighting the firm's specialization in securities class action lawsuits aimed at helping investors recover their losses.
See More
Vital Farms Securities Class Action Notice
- Class Action Notice: Rosen Law Firm reminds investors who purchased Vital Farms securities between May 8, 2025, and February 26, 2026, that they must apply to be lead plaintiff by May 26, 2026, or risk losing their right to compensation.
- Lawsuit Background: The lawsuit alleges that Vital Farms downplayed the risks associated with delays in its new ERP system rollout, failing to disclose the impact of these delays on its 2025 earnings guidance and EPS consensus, resulting in investor losses when the truth emerged.
- Law Firm's Credentials: Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, being ranked first by ISS Securities Class Action Services in 2017, showcasing its successful track record and expertise in the field.
- Investor Advisory: Investors are advised to choose their legal counsel wisely, as many firms issuing notices lack actual litigation experience; Rosen Law Firm emphasizes selecting counsel with a proven track record to ensure effective protection of their rights.
See More
Vital Farms Securities Class Action Reminder
- Class Action Notice: Rosen Law Firm reminds investors who purchased Vital Farms securities between May 8, 2025, and February 26, 2026, that they must apply to be lead plaintiff by May 26, 2026, or risk losing their representation in the class action lawsuit.
- Potential Compensation Opportunity: Investors participating in the class action may be entitled to compensation without any upfront costs, indicating a risk-free avenue for affected investors to seek recovery, thereby enhancing investor confidence in the process.
- Lawsuit Background: The lawsuit alleges that Vital Farms downplayed the risks associated with delays in rolling out its new ERP system and failed to disclose the impact of these delays on its 2025 earnings guidance and EPS consensus, resulting in investor losses when the truth emerged.
- Law Firm's Advantage: Rosen Law Firm is renowned for its successful track record in securities class actions, having recovered over $438 million for investors in 2019 alone, showcasing its expertise and resource advantages in handling such cases.
See More
Vital Farms Q1 2026 Earnings Call Insights
- Underperformance in Q1: Vital Farms reported net revenue of $187.2 million for Q1 2026, a 15.4% year-over-year increase, yet the results fell short of expectations due to unsustainable price gaps, prompting management to emphasize the need for rapid adaptation to control costs.
- Adjusted EBITDA Guidance: The company has lowered its adjusted EBITDA guidance for 2026 to a range of $0 to $10 million, anticipating a negative impact of $32 million from supply management costs, indicating increased cash flow pressures.
- Strategic Contraction: Vital Farms has decided to exit its butter business and pause construction on the Vital Crossroads facility in Indiana, reducing capital expenditure guidance to $70 million to $75 million, reflecting a cautious approach to future investments.
- Market Outlook: Management expects revenue-generating volume growth to turn positive in Q3 and anticipates growth acceleration in Q4, despite current pricing pressures and oversupply challenges, aiming to restore gross margins to 30% by 2027.
See More
